147 related articles for article (PubMed ID: 35383587)
21. Hepatocellular adenomas in a large community population, 2000 to 2010: reclassification per current World Health Organization classification and results of long-term follow-up.
Shafizadeh N; Genrich G; Ferrell L; Kakar S
Hum Pathol; 2014 May; 45(5):976-83. PubMed ID: 24746201
[TBL] [Abstract][Full Text] [Related]
22. [Hepatocellular carcinoma in an inflammatory adenoma with β-catenin mutation in a patient with hepatocellular adenomatosis due to germline mutation in HNF1α].
Ridder DA; Duret D; Wörns MA; Schotten S; Heinrich S; Kloth M; Springer E; Roth W; Straub BK
Z Gastroenterol; 2019 Jan; 57(1):46-51. PubMed ID: 30641602
[TBL] [Abstract][Full Text] [Related]
23. Hepatocellular adenoma in Taiwan: Distinct ensemble of male predominance, overweight/obesity, and inflammatory subtype.
Huang WC; Liau JY; Jeng YM; Liu KL; Lin CN; Song HL; Tsai JH
J Gastroenterol Hepatol; 2020 Apr; 35(4):680-688. PubMed ID: 31698521
[TBL] [Abstract][Full Text] [Related]
24. Inflammatory hepatocellular adenomas developed in the setting of chronic liver disease and cirrhosis.
Calderaro J; Nault JC; Balabaud C; Couchy G; Saint-Paul MC; Azoulay D; Mehdaoui D; Luciani A; Zafrani ES; Bioulac-Sage P; Zucman-Rossi J
Mod Pathol; 2016 Jan; 29(1):43-50. PubMed ID: 26516697
[TBL] [Abstract][Full Text] [Related]
25. Diagnosis of hepatocellular adenoma in men before onset of diabetes in HNF1A-MODY: Watch out for winkers.
Haring MPD; Vriesendorp TM; Klein Wassink-Ruiter JS; de Haas RJ; Gouw ASH; de Meijer VE
Liver Int; 2019 Nov; 39(11):2042-2045. PubMed ID: 31483937
[TBL] [Abstract][Full Text] [Related]
26. A Limited Immunohistochemical Panel Can Subtype Hepatocellular Adenomas for Routine Practice.
Larson BK; Guindi M
Am J Clin Pathol; 2017 Jun; 147(6):557-570. PubMed ID: 28472207
[TBL] [Abstract][Full Text] [Related]
27. Simultaneous occurrence of focal nodular hyperplasia and HNF1A-inactivated hepatocellular adenoma: a collision tumor simulating a composite FNH-HCA.
Shih A; Lauwers GY; Balabaud C; Bioulac-Sage P; Misdraji J
Am J Surg Pathol; 2015 Sep; 39(9):1296-300. PubMed ID: 26274031
[TBL] [Abstract][Full Text] [Related]
28. Malignant transformation of hepatocellular adenoma: report of a case.
Mouhoub M; Miry A; Haloui A; Karich N; Kamaoui I; Soufi M; Bennani A
Pan Afr Med J; 2020; 35():92. PubMed ID: 32636990
[TBL] [Abstract][Full Text] [Related]
29. Clinicopathologic characterization of hepatocellular adenomas in men: a multicenter experience.
González IA; Torbenson M; Sharifai N; Byrnes K; Chatterjee D; Kakar S; Yeh MM; Wu TT; Zhang X; Jain D
Hum Pathol; 2023 Aug; 138():24-33. PubMed ID: 37245629
[TBL] [Abstract][Full Text] [Related]
30. New monoallelic (partial tandem duplication) mutation of HNF1a gene in steatotic hepatocellular adenoma.
Sakellariou S; Morgan Y; Heaton N; Portmann B; Quaglia A; Tobal K
Eur J Gastroenterol Hepatol; 2011 Jul; 23(7):623-7. PubMed ID: 21566527
[TBL] [Abstract][Full Text] [Related]
31. Expression of liver fatty acid binding protein in hepatocellular carcinoma.
Cho SJ; Ferrell LD; Gill RM
Hum Pathol; 2016 Apr; 50():135-9. PubMed ID: 26997447
[TBL] [Abstract][Full Text] [Related]
32. Incidental inflammatory adenoma with β-catenin activation in the setting of paediatric NASH.
Oliveira S; Samba AK; Towbin AJ; Gupta A; Geller JI; Nathan JD; Kohli R
Pediatr Obes; 2018 Jan; 13(1):70-73. PubMed ID: 27780309
[TBL] [Abstract][Full Text] [Related]
33. Focal β-catenin mutation identified on formalin-fixed and paraffin-embedded inflammatory hepatocellular adenomas.
Saldarriaga J; Bisig B; Couchy G; Castain C; Zucman-Rossi J; Balabaud C; Sempoux C; Bioulac-Sage P
Histopathology; 2017 Dec; 71(6):989-993. PubMed ID: 28618047
[TBL] [Abstract][Full Text] [Related]
34. A Scoping Review of the Classification, Diagnosis, and Management of Hepatic Adenomas.
Aziz H; Brown ZJ; Eskander MF; Aquina CT; Baghdadi A; Kamel IR; Pawlik TM
J Gastrointest Surg; 2022 Apr; 26(4):965-978. PubMed ID: 35083725
[TBL] [Abstract][Full Text] [Related]
35. Hepatic adenomas caused by somatic HNF1A mutations in children with biallelic mismatch repair gene mutations.
Holter S; Pollett A; Zogopoulos G; Kim H; Schwenter F; Asai K; Gallinger S; Clendenning M; Steinbach G; Jacobson A; Boycott KM
Gastroenterology; 2011 Feb; 140(2):735-6. PubMed ID: 21182953
[No Abstract] [Full Text] [Related]
36. Subclassification of hepatocellular adenomas: practical considerations in the implementation of the Bordeaux criteria.
Miller GC; Campbell CM; Manoharan B; Bryant R; Cavallucci D; O'Rourke N; Clouston AD
Pathology; 2018 Oct; 50(6):593-599. PubMed ID: 30149989
[TBL] [Abstract][Full Text] [Related]
37. Hepatocellular neoplasms with loss of liver fatty acid binding protein: Clinicopathologic features and molecular profiling.
Joseph NM; Blank A; Shain AH; Gill RM; Umetsu SE; Shafizadeh N; Torbenson MS; Kakar S
Hum Pathol; 2022 Apr; 122():60-71. PubMed ID: 35104461
[TBL] [Abstract][Full Text] [Related]
38. Chromosomal and genetic alterations in human hepatocellular adenomas associated with type Ia glycogen storage disease.
Kishnani PS; Chuang TP; Bali D; Koeberl D; Austin S; Weinstein DA; Murphy E; Chen YT; Boyette K; Liu CH; Chen YT; Li LH
Hum Mol Genet; 2009 Dec; 18(24):4781-90. PubMed ID: 19762333
[TBL] [Abstract][Full Text] [Related]
39. Hepatocellular adenomas: is there additional value in using Gd-EOB-enhanced MRI for subtype differentiation?
Auer TA; Fehrenbach U; Grieser C; Penzkofer T; Geisel D; Schmelzle M; Müller T; Bläker H; Seehofer D; Denecke T
Eur Radiol; 2020 Jun; 30(6):3497-3506. PubMed ID: 32086574
[TBL] [Abstract][Full Text] [Related]
40. [Transformation of hepatic adenoma into hepatocellular carcinoma in patients with prolonged use of oral contraceptives].
Herman P; Machado MA; Volpe P; Pugliese V; Vianna MR; Bacchella T; Machado MC; Pinotti HW
Rev Hosp Clin Fac Med Sao Paulo; 1994; 49(1):30-3. PubMed ID: 8029613
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
